Koers Beijing Science Sun Pharmaceutical Co., Ltd.
Aandelen
300485
CNE100002110
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
7,16 CNY | -7,73% | -2,45% | -32,39% |
Omzet 2022 | 735 mln. 101 mln. 94,81 mln. | Omzet 2023 | 477 mln. 65,77 mln. 61,51 mln. | Marktkapitalisatie | 5,1 mld. 704 mln. 658 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 205 mln. 28,29 mln. 26,46 mln. | Nettowinst (verlies) 2023 | 103 mln. 14,21 mln. 13,29 mln. | EV/omzet 2022 | 6,33 x |
Nettoliquiditeiten 2022 | 1,12 mld. 155 mln. 145 mln. | Nettoliquiditeiten 2023 | 1,17 mld. 162 mln. 151 mln. | EV/omzet 2023 | 8,24 x |
K/w-verhouding 2022 |
27,9
x | K/w-verhouding 2023 |
50,4
x | Werknemers | - |
Dividendrendement 2022 |
0,72% | Dividendrendement 2023 |
0,21% | Vrij verhandelbaar | 41,18% |
1 dag | -7,73% | ||
1 week | -2,45% | ||
Lopende maand | -14,15% | ||
1 maand | -13,53% | ||
3 maanden | -23,50% | ||
6 maanden | -35,44% | ||
Lopend jaar | -32,39% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Biao Ma
CEO | Chief Executive Officer | 60 | 05-07-01 |
Ning Zhang
ADM | Chief Administrative Officer | 45 | 28-01-21 |
Meng Wei Song
CTO | Chief Tech/Sci/R&D Officer | 49 | 01-03-01 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Yan Heng Song
BRD | Director/Board Member | 51 | 26/01 |
Xue Feng Wang
BRD | Director/Board Member | 46 | 01-01-99 |
Biao Ma
CEO | Chief Executive Officer | 60 | 05-07-01 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 34 M€ | +2,14% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 7,16 | -7,73% | 11 119 160 |
25-04-24 | 7,76 | +1,70% | 3 551 300 |
24-04-24 | 7,63 | +1,87% | 3 270 000 |
23-04-24 | 7,49 | +1,77% | 2 851 382 |
22-04-24 | 7,36 | +0,27% | 2 699 199 |
slotkoers Shenzhen S.E., 26 april 2024
Meer koersenWinst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-32,39% | 476 mln. | |
+25,83% | 661 mld. | |
+27,00% | 566 mld. | |
-6,76% | 352 mld. | |
+20,34% | 332 mld. | |
+3,00% | 283 mld. | |
+13,09% | 231 mld. | |
+5,46% | 200 mld. | |
-9,61% | 195 mld. | |
-6,26% | 145 mld. |